Navigation Links
New Drug for Rheumatoid Arthritis Looks Promising.

Patients with rheumatoid arthritis hopes have been raised with Roche announcing that its new drug showed positive results and was safe without any side effects according to its key study. Drug maker Roche Holding AG will file the drug Actemra for regulatory approval in Europe and the U.S. later this year.

Actemra was developed by Japanese pharmaceutical company Chugai Pharmaceutical Co. (4519.TO), which is controlled by Roche. Roche owns the rights to market Actemra outside Japan.

Two other drugs rituximab (Rituxan), abatacept (Orencia) are already there to reduce signs and symptoms of RA, improve physical function and health status, and slow joint damage progression.

Sufferers of rheumatoid arthritis, or RA, begin to experience progressive joint damage early in the disease. The disease differs from what is popularly known as arthritis, typically associated with age-related joint pain; RA is a far more serious inflammatory disease that leads to destruction of cartilage and bone, and can lead to disability.

The new treatment option Actemra in combination with traditional drugs achieved a significant improvement in disease signs and symptoms after 24 weeks, compared to those treated with the traditional drugs alone.

The heterogeneity of the disease is one of the reasons why no single therapy is effective for all patients or for one patient at all times. Disease-modifying anti-rheumatic drugs such as the anti-tumor necrosis factor (TNF) agents etanercept (Enbrel), infliximab (Remicade), and adalimumab (Humira), in combination with methotrexate, have significant anti-inflammatory and joint-protecting activity.

Abatacept, rituximab, and tocilizumab all achieved better clinical results in combination with methotrexate than when used as monotherapy.

Currently available drugs that target a protein called tumour necrosis factor, or TNF, have helped revolutionise treatment for rheum
'"/>




Page: 1 2

Related medicine news :

1. New treatment for Rheumatoid Arthritis
2. New Rheumatoid Arthritis Treatment
3. New Rheumatoid Arthritis Treatment
4. Consumption Of Red Meat Found To Double The Risk of Rheumatoid Arthritis
5. The Link Between Rheumatoid Arthritis And Heart Failure
6. Smoking during pregnancy increases risk of Rheumatoid Arthritis.
7. Good News For Those Of You Suffering From Rheumatoid Arthritis
8. Mineral Oil exposure increases risk of Rheumatoid Arthritis
9. Mineral Oil exposure increases risk of Rheumatoid Arthritis
10. Novel drug holds promise for treatment of Rheumatoid Arthritis
11. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...users of Blackberry email devices on its addictive... the devices could get so addictive that owners mi...ith treatment that is similar to that given to dru...had been carried out by Rutgers University School,...
... fleeting that we could use it in just one tenth o...rch in this area. Researchers say that impressions...vement, because all it needs is just a split secon...decide whether he is worthy of companionship and t...
...st mites in the bedroom can be achieved by replaci...ion, according to a new study.// In “Distribution...urope: The European Community Respiratory Health S...al Institute of Medical Research, Barcelona, Spain...
...ath syndrome has been the cause of many infant dea... sleeps on its back. In a bid to investigate the//..., researchers discovered that infants born with an...were prone to the risk of SIDS. The study has un...
Other Medicine News:Health News:Replacing Old Mattress, Adding Ventilation Reduces Mites 2
(Date:8/18/2008)...fe expectancy for people with,Down syndrome, WASH...world of Down,syndrome, ,Mr. C, is a rarity. A rea...ast 16 years, at seventy, ,Mr. C, has well surpass...wn syndrome, currently in the,late fifties, but in... does,not exhibit clinical symptoms of Alzheimer,s...
(Date:8/18/2008)...n Phase I -, PRINCETON, N.J. and SAN DIEGO, Aug. ...nical stage biotechnology company committed to the...tening and life-altering,infectious diseases, toda...2 by the U.S. Patent and Trademark Office, coverin...in Phase I development for the treatment of HIV-1,...
(Date:8/14/2008)...-- AstraZeneca (NYSE: AZN ),today announced an in...Centre Singapore (NCCS) and the National Universit... The collaboration, which is spelt out in a,Memora... aims to further,build AstraZeneca,s drug developm...ccess to new medicines of potential benefit to pat...
(Date:8/14/2008).../ -- The Clinical Trials,Bootcamp announces its in...nical coordinators, clinical research staff and ot...d in Boca Raton at the Boca Resort from May,14-17t...ators, monitors and,other industry personnel will ...cal trials into a practice, as well as how to take...
Breaking Medicine Technology:Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 5549 1Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 5549 2Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 5549 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 1Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 4Studies provide insights into lung disease and lung function in young adults 19977 1Studies provide insights into lung disease and lung function in young adults 19977 2Studies provide insights into lung disease and lung function in young adults 19977 3Crdentia Announces 2008 First Quarter Results 19972 1Crdentia Announces 2008 First Quarter Results 19972 2Crdentia Announces 2008 First Quarter Results 19972 3Crdentia Announces 2008 First Quarter Results 19972 4Crdentia Announces 2008 First Quarter Results 19972 5Crdentia Announces 2008 First Quarter Results 19972 6Crdentia Announces 2008 First Quarter Results 19972 7
... UCB Announces Positive Top-Line Phase III Results... Onset Seizures in,Paediatric Patients from One Mo...gium - April 20, 2007 - UCB today announced,positi...,randomized, multi-centre, placebo-controlled stu...pra® (levetiracetam) (20-50,mg/kg/day) as adju...
...PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 23, 2007 -...ts to date from two separate,Phase 2 clinical tria...ronic kidney disease (CKD) patients. The data show...Hematide could,correct anemia when administered mo...in dialysis patients previously treated with,three...
Other Medicine Technology:UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 2Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 3
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish.
Solid 16 mm blades. Self-locking mechanism. Dull finish.
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish.
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish.
Medicine Products: